Concepedia

Cherrie K. Donawho

CK

Statistics

Publications

45

Citations

3.8K

H-Index

30

Active since

1988

Affiliations

Abbott Fund(Current)

The University of Texas MD Anderson Cancer Center

AbbVie (United States)

Abbott (United States)

Centre for Cancer Biology

Cherrie K. Donawho is an author at Abbott Fund specializing in medicine, tumor microenvironment, and tumor biology.

Top concepts

Publications per year

1988–2021

45

Publications

45

ABT-888, an Orally Active Poly(ADP-Ribose) Polymerase Inhibitor that Potentiates DNA-Damaging Agents in Preclinical Tumor Models

Cherrie K. Donawho, Yan Luo, Yanping Luo et al. · Clinical Cancer Research · 2007 · 762 citations · Full text

Discovery of the Poly(ADP-ribose) Polymerase (PARP) Inhibitor 2-[(<i>R</i>)-2-methylpyrrolidin-2-yl]-1<i>H</i>-benzimidazole-4-carboxamide (ABT-888) for the Treatment of Cancer

Thomas D. Penning, Gui‐Dong Zhu, Viraj B. Gandhi et al. · Journal of Medicinal Chemistry · 2008 · 264 citations · Full text

Mechanistic Dissection of PARP1 Trapping and the Impact on <i>In Vivo</i> Tolerability and Efficacy of PARP Inhibitors

Todd A. Hopkins, Yan Shi, Luis E. Rodrı́guez et al. · Molecular Cancer Research · 2015 · 257 citations

PARP1 Trapping by PARP Inhibitors Drives Cytotoxicity in Both Cancer Cells and Healthy Bone Marrow

Todd A. Hopkins, William B. Ainsworth, Paul A. Ellis et al. · Molecular Cancer Research · 2018 · 250 citations

Iniparib Nonselectively Modifies Cysteine-Containing Proteins in Tumor Cells and Is Not a <i>Bona Fide</i> PARP Inhibitor

Xuesong Liu, Yan Shi, David Maag et al. · Clinical Cancer Research · 2011 · 175 citations · Full text

1–5 of 45